Bristol-Myers Squibb Co. is a
prestigious company university
established in 1887 in United States. It is represented
by 324 scientists in the AD Scientific Index. The
university’s scientists are particularly concentrated in
Natural Sciences (90 scientists), Medical and Health Sciences (76 scientists), and Engineering & Technology (23 scientists).
* Total H Index Rankings
Ranking Based
On Selection: 1
Oncology
Breast Cancer
Immunotherapeutics
Clinical Trials
Molecularly Targeted Agents
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
26
0.839
* Total H Index Rankings
Ranking Based
On Selection: 2
Oncology
Immune-oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
18
0.600
* Total H Index Rankings
Ranking Based
On Selection: 3
Oncology
Informatics
Genetics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
21
0.808
* Total H Index Rankings
Ranking Based
On Selection: 4
Oncology
Immuno-Oncology
Cancer drug resitance
Drug discovery
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
* Total H Index Rankings
Ranking Based
On Selection: 5
Oncology
Immuno-Oncology
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
8
0.571
* Total H Index Rankings
Ranking Based
On Selection: 6
Oncology
Pharmacokinetics
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
7
0.500
* Total H Index Rankings
Ranking Based
On Selection: 7
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
11
0.846
* Total H Index Rankings
Ranking Based
On Selection: 8
Oncology
cognitive neuroscience
molecular neurobiology
theoretical physics
general intelligence
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
2
1
0.500
Dimitrios Zardavas
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
31
26
0.839
Oncology
Breast Cancer
Immunotherapeutics
Clinical Trials
Molecularly Targeted Agents
Erick Morris
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
30
18
0.600
Oncology
Immune-oncology
Danielle Greenawalt
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
26
21
0.808
Oncology
Informatics
Genetics
Leila Dardaei
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
17
16
0.941
Oncology
Immuno-Oncology
Cancer drug resitance
Drug discovery
Roland Meier
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
8
0.571
Oncology
Immuno-Oncology
Richard Smykla
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
14
7
0.500
Oncology
Pharmacokinetics
Joseph Benci
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
13
11
0.846
Tyler Santomaso
Bristol-Myers Squibb Co.
New York, United States
H-Index Metrics
Total
Last 6 Years
Last 6 Years / Total
2
1
0.500
Oncology
cognitive neuroscience
molecular neurobiology
theoretical physics
general intelligence